Releases and presentations

Releases and presentations

Stock exchange and press releases of BBS will be published on these pages. Releases are published in Finnish and in English.

Contact information for the media: info@bbs-artebone.fi from which you can also request additional media material

Archived releases can be found:
2018
2019
2020
2021

19.11.2021 BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc ja Riverfort Global Opportunities PCC Ltd
17.11.2021 BBS-Bioactive Bone Substitutes Plc: Claims of the patent application for the manufacturing of the ARTEBONE® product have been approved in the USA
30.09.2021 BBS-Bioactive Bone Substitutes Plc has agreed on a capital facility to strengthen the company's working capital – further enables the CE marking application
07.09.2021 BBS-Bioactive Bone Substitutes Plc: Animal test results completed contributing on their part to submitting the CE marking application
25.08.2021 BBS-Bioactive Bone Substitutes Plc: CORRECTION: Half-Year Report January 1st –June 30th 2021 (Unaudited)
25.08.2021 BBS-Bioactive Bone Substitutes Plc: Half-Year Report January 1st –June 30th 2021 (Unaudited)
29.04.2021 BBS-Bioactive Bone Substitutes Plc - CORRECTION: Decisions of the Annual General Meeting 2021
28.04.2021 BBS-Bioactive Bone Substitutes Plc: Decisions of the Annual General Meeting 2021
26.04.2021 BBS-Bioactive Bone Substitutes Plc: Submission of CE marking application for ARTEBONE® products moves to August
08.04.2021 BBS-Bioactive Bone Substitutes Plc: CORRECTION TO THE INVITATION TO THE ANNUAL GENERAL MEETING